U.S. FDA Chief Defends Approval of Zogenix's 'unique' Pain Drug Zohydro

U.S. FDA chief defends approval of Zogenix's 'unique' pain drug Zohydro
U.S. Food and Drug Administration Commissioner Margaret Hamburg on Thursday defended the agency's approval of Zogenix Inc's Zohydro, saying the powerful prescription opioid offered a unique option to help treat pain. Law enforcement officials, doctors and addiction treatment specialists are concerned that Zohydro would set off a wave of addiction similar to problems with the original form of …
Addiction Treatment – Yahoo News Search Results

Find More Addiction Treatment Information…